SLC22A12 and hyperuricemia: Our results indicate that EST can reduce UA uptake via URAT1 and GLUT9 transporters while reducing the expression of renal transporter OAT1, thereby inhibiting UA reabsorption and promoting UA excretion, ultimately alleviating hyperuricemia.